Cabot (CBT)
(Delayed Data from NYSE)
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Cabot (CBT) Q3 Earnings & Revenues Miss Estimates, Fall Y/Y
by Zacks Equity Research
Cabot (CBT) lags third-quarter earnings and revenue estimates due to low volumes in its segments.
Compared to Estimates, Cabot (CBT) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Cabot (CBT) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Koppers (KOP) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Koppers (KOP) delivered earnings and revenue surprises of 16.67% and 8.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Kronos Worldwide (KRO) delivered earnings and revenue surprises of -170% and 16.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Announces Updates on Current Demand Scenario
by Zacks Equity Research
Cabot (CBT) expects EBIT in the Performance Chemical segment to be slightly higher in the fiscal third quarter than in the second quarter.
Why Is Cabot (CBT) Up 8.2% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
by Zacks Equity Research
Cabot (CBT) gains on strength in its Reinforcement Materials segment in Q2, offset by weakness in Performance Chemicals.
Cabot (CBT) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 3.91% and 1.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Q1 Earnings Beat Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 25% and 1.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
FMC (FMC) Beats Q1 Earnings Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 2.31% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Buys Solar Farm in Japan, Spurs Sustainability Goals
by Zacks Equity Research
The Chiba solar farm acquired by Cabot (CBT) generates up to 3,500 megawatt-hours (MWh) of electricity per year, powering approximately 700 Japanese houses per year.
Cabot (CBT) Unveils Technology Platform for Reinforcing Carbons
by Zacks Equity Research
Cabot's (CBT) EVOLVE Sustainable Solutions technology platform is aimed at boosting the development of sustainable reinforcing carbons.
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot are part of the Zacks Industry Outlook article.
4 Diversified Chemical Stocks to Escape Industry Challenges
by Anindya Barman
Demand worries due to weakness in certain markets and raw material cost inflation pose headwinds for the Zacks Chemicals Diversified industry. APD, DD, ALB and CBT are poised to navigate the industry challenges.
Cabot (CBT) to Unveil Battey Application Center in Europe
by Zacks Equity Research
The new technology center will allow Cabot (CBT) to enhance its battery materials development capabilities.
Cabot's (CBT) Earnings and Revenues Outshine Estimates in Q1
by Zacks Equity Research
Cabot's (CBT) Q1 performance reflects a decline in volumes due to consumer destocking and COVID-19 outbreaks in China. Weak demand and unfavorable currency movements also played a role.
Cabot (CBT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 2.08% and 11.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) to Boost CCA Capacity to Support EV Transition
by Zacks Equity Research
Cabot's (CBT) investment in Carbon additives is expected to solidify its position as a leading producer of CCAs for lithium-ion battery applications.
Why Is Cabot (CBT) Up 2% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Earnings and Sales Surpass Estimates in Q4
by Zacks Equity Research
Cabot's (CBT) results were aided by higher margins and stronger volumes in the fiscal fourth quarter.
Cabot (CBT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 4.73% and 7.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Matches Q3 Earnings Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 0% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Kronos Worldwide (KRO) delivered earnings and revenue surprises of -51.35% and 10.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Univar (UNVR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Univar (UNVR) delivered earnings and revenue surprises of 12% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot's (CBT) Shares Up 17% YTD: What's Driving the Stock?
by Zacks Equity Research
Cabot (CBT) gains on strong underlying demand across its businesses, its disciplined execution of operations and strategic acquisition.